SCHEMBL20813385

SCHEMBL20813385

CC(C)NP(=O)(CCI)NC(C)C

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
BCHE P06276 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24015444 0.79 ALDH1A1 (0.42) ALDH1A1BCHEHIF1A
SCHEMBL24065129 0.77 ALDH1A1 (0.40) ALDH1A1BCHEHIF1A
SCHEMBL24067438 0.75 TRPM8 (0.43) ALDH1A1BCHEHIF1A
SCHEMBL14600549 0.74 ALDH1A1 (0.42) ALDH1A1BCHEHIF1A
SCHEMBL25670652 0.71 ALDH1A1 (0.36) ALDH1A1BCHEHIF1A
SCHEMBL22045458 0.69 ALDH1A1 (0.42) ALDH1A1BCHEHIF1A
SCHEMBL24064975 0.67 ALDH1A1 (0.36) ALDH1A1BCHEHIF1A
SCHEMBL11023549 0.62 ALDH1A1 (0.53) ALDH1A1BCHEHIF1A
SCHEMBL22388992 0.62 ALDH1A1 (0.36) ALDH1A1BCHEHIF1A
SCHEMBL4336527 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327882-A2 ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER The Board of Trustees of the Leland Stanford Junior University (US) 2024-02-28 EP disclosed
WO-2023077083-A1 ENPP1 INHIBITORS AS INHIBITORS OF METASTASIS ANGARUS THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed
WO-2019051269-A1 ENPP1 INHIBITORS AND THEIR USE FOR THE TREATMENT OF CANCER THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2019-03-14 WO disclosed